Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Becaplermin Product Approval Information - Licensing Action 12/16/97

Proper name: Becaplermin
Tradename: Regranex
Manufacturer: OMJ Pharmaceuticals, Inc, Manati, Puerto Rico, License #1196
Indication for Use: Treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond, and have adequate blood supply
Approval Date: 12/16/97
Type of submission: Biologics license application


Approval Letter (PDF)

Label (PDF)

Reviews (PDF)
    Clinical (70 pages)
    CMC (9 pages)
    Pharmacology (68 pages)
    Statistical (14 pages)

Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English